1. Ballantyne CM, Podet EJ, Patsch WP, Harati Y, Appel V, Gotto AM, Young JB (1989) Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA 262:53?56
2. Bojanovski M, Gregg RE, Wilson DM, Brewer HB Jr (1987) Semi-automated enzyme-linked immunosorbent assay (ELISA) for the quantification of apolipoprotein B using monoclonal antibodies. Clin Chim Acta 170:271?280
3. Canafax DM, Simmons RL, Sutherland DER, Fryd DS, Strand MH, Ascher NL, Payne WD, Najarian JS (1986) Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomised trial comparing cyclosporin versus antilymphocyte globulin-azathioprine. Transplant Proc 18 [Suppl 1]:192?196
4. Chan MK, Varghese Z, Persaud JW, Fernando ON, Moorhead JF (1981) The role of multiple pharmaco-therapy in the pathogenesis of hyperlipidemia after renal transplantation. Clin Nephrol 15:309?313
5. Derfler K, Hayde M, Balcke P, Widhalm K (1988) Pathologic decrease in lipoprotein lipase activity in renal transplant recipients immunosuppressed with cyclosporine A. XXVth Congress of the European Dialysis and Transplant Association, Madrid, September 5?8, 1988. Abstract book, p 116